PKS Advisory Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
PKS Advisory Services's PFE Position: Q1 2026 in Review
PKS Advisory Services sold out of Pfizer (PFE) in Q1 2026, closing a stake of 9,581 shares — an estimated $239K sold.
PKS Advisory Services first reported a position in PFE in Q4 2024 and held it in 5 quarters. The position peaked at $327K in Q1 2025. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- PKS Advisory Services reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- PKS Advisory Services sold 9,581 Pfizer shares in Q1 2026, an estimated $239K.
- PKS Advisory Services first reported a position in Pfizer in Q4 2024 and held it in 5 quarters.
- PKS Advisory Services's Pfizer position peaked at $327K in Q1 2025.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on PKS Advisory Services's 13F filing for Q1 2026, filed 13 May 2026.